Artificial liver support systems in the management of complications of cirrhosis.
about
The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-AnalysisInitial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure.TIPE2 mRNA Level in PBMCs Serves as a Novel Biomarker for Predicting Short-Term Mortality of Acute-on-Chronic Hepatitis B Liver Failure: A Prospective Single-Center Study.Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitisTreatment of hepatorenal syndrome.Innate immune dysfunction in acute and chronic liver disease.Acute-on-chronic liver failure: a review.Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions.Clearing of toxic substances: are there differences between the available liver support devices?Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality.Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.Clinical observation on the treatment of acute liver failure by combined non-biological artificial liver.Short-term efficacy of treating hepatitis B virus-related acute-on-chronic liver failure based on cold pattern differentiation with hot herbs: A randomized controlled trial.Plasma interleukin-10 predicts short-term mortality of acute-on-chronic hepatitis B liver failure.Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients.Management of hepatic encephalopathy
P2860
Q26752443-B6F094AE-8015-4E6C-96B3-194062E57338Q35848248-A783928D-5DBE-4073-AD90-B6709DFBF08CQ36195966-6E8898B9-9245-4BD5-9C39-047BF46430DFQ37086190-D63A0510-5361-4B0B-B332-6BFBD304E980Q37605883-D6C60A16-9EB1-4C5E-BEE5-ADE52B45B6F6Q37666863-2F95334F-0B3B-4D26-B3D6-BABCF0B20341Q37729728-671BF4E8-7301-4F31-8CF6-4AF0B771730DQ37903856-4D144724-0589-489B-955C-0B9ED602D5BDQ37913529-3C61346C-9955-4311-80A7-39903B538B54Q38471899-105DF10F-79BB-427B-8966-4037268E5CE6Q38635623-8ECF4115-389E-48CF-9122-A63B7E562131Q40372387-F0379B31-21C5-48C6-B181-273A39E76FA9Q40661488-85AFD62D-9538-4AF8-910E-BE8DF814B940Q40821445-9D127043-E775-4344-974B-5E79D2FAE374Q43227896-B99D9626-0578-432A-958B-B245DC2BFEE6Q58687496-91522B9F-A554-4AC2-AC04-0EA4926C5D1E
P2860
Artificial liver support systems in the management of complications of cirrhosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Artificial liver support systems in the management of complications of cirrhosis.
@en
Artificial liver support systems in the management of complications of cirrhosis.
@nl
type
label
Artificial liver support systems in the management of complications of cirrhosis.
@en
Artificial liver support systems in the management of complications of cirrhosis.
@nl
prefLabel
Artificial liver support systems in the management of complications of cirrhosis.
@en
Artificial liver support systems in the management of complications of cirrhosis.
@nl
P2093
P356
P1476
Artificial liver support systems in the management of complications of cirrhosis.
@en
P2093
Nathan A Davies
Rajiv Jalan
Sambit Sen
P304
P356
10.1055/S-2008-1040324
P577
2008-02-01T00:00:00Z